Tweets
RheumNow’s expanded coverage of the #ACR26 meeting is sponsored by UCB.
All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
13 minutes 3 seconds ago
Links:
Dr. John Cush @RheumNow ( View Tweet )
32 minutes 26 seconds ago
When you don’t use anti-fibrotics in RA-ILD
RA-ILD occurs in somewhere up to 10% of patients with RA. It is a serious complication with significant morbidity and mortality attached to it.
https://t.co/K6tEtjf9Gm https://t.co/Hehv0HbD7y
Dr. John Cush @RheumNow ( View Tweet )
11 hours 14 minutes ago
EGPA Treatment: A new Era with the E-MERGE trial?
EGPA is the rarest of the ANCA-associated vasculitides. Compared with GPA and MPA, EGPA has a mechanistically distinct pathophysiology involving eosinophil-mediated inflammation. This distinct mechanism has driven the https://t.co/gP5y6rCUJH
Dr. John Cush @RheumNow ( View Tweet )
12 hours 14 minutes ago
The shifting sands of glucocorticoid use in SLE
Despite the rapid development of emerging therapies for SLE, glucocorticoids remain an important component of disease management. "How well do our current corticosteroid prescribing habits align with current treatment guidelines?" https://t.co/kyZWVERLMP
Dr. John Cush @RheumNow ( View Tweet )
13 hours 14 minutes ago
RheumNow’s expanded coverage of #ACR26 annual meeting is sponsored by UCB.
All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
13 hours 44 minutes ago
RheumNow’s expanded coverage of #ACR26 annual meeting is sponsored by Eli Lilly and Company.
All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
14 hours 13 minutes ago
ACR 2026 RheumNow Day 2 Recap https://t.co/YNEmDFBdzv
Links:
Dr. John Cush @RheumNow ( View Tweet )
14 hours 14 minutes ago
RheumNow’s expanded coverage of the #ACR26 annual meeting is sponsored by UCB.
All content is independently selected by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
15 hours 13 minutes ago
RheumNow’s expanded coverage of the #ACR26 Annual Meeting is sponsored by Beeline Medicines, Boehringer Ingelheim, Bristol Myers Squibb, and Tonix. All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
15 hours 59 minutes ago
SPACE, 67 axSpA patients over about 2 years: low dose CT was 2.3 to 2.7 times more responsive to spinal change than mSASSS, followed by MRI bone spurs (2.1). Key finding: low dose CT was the most responsive modality, and absolute progression was low with all methods. @rheumnow
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
16 hours 16 minutes ago
LLM extraction from 488 PsA records (Columbia): 42.6% met full CASPAR criteria and 43.2% had inflammatory features without full CASPAR. Key finding: CASPAR features were extracted at scale, while cDAPSA was documented in 4.9% of records. @rheumnow #ACR26 Abstract#1348
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
16 hours 36 minutes ago
JAKi vs TNFi in higher-CV-risk RA: target trial emulation of 17607 matched pairs found MACE HR 1.02, but higher mortality (HR 1.21) and HF admission (HR 1.11). Findings refine results from ORAL Surveillance and support individualized JAKi agent selection #1900 @Rheumnow #ACR26 https://t.co/uDuOCPa6bf
Mrinalini Dey @DrMiniDey ( View Tweet )
16 hours 36 minutes ago
Fibromyalgia was present in 9.3% of 151 SpA patients, with ASDAS CRP 3.7 vs 2.2 without it. Key finding: fibromyalgia was associated with higher disease activity and poorer function, and the six item FiRST had a negative predictive value of 98.4%. @rheumnow #ACR26 Abstract#1354
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
16 hours 36 minutes ago
Nociplastic pain in axSpA (OHSU): 32.5% of 83 patients had FSQ of 13 or more. FSQ correlated with ASDAS CRP (r 0.53) and lower pressure pain thresholds. Key finding: nociplastic features were common and associated with higher disease activity scores and female sex. Watch my video
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
16 hours 36 minutes ago